NCT01129609

Brief Summary

The primary endpoint is successful secondary endovascular treatment with the Talent Converter stent graft of subjects having received prior endovascular repair of infrarenal abdominal aortic or aortoiliac aneurysms using the Talent or AneuRx Bifurcated Stent Grafts, in which there is inadequate proximal fixation, seal, overlapping of modular components or unattainable contralateral limb cannulation. Treatment success is defined as a composite of successful vessel access, successful insertion of the delivery system, successful deployment of the Converter stent graft at the intended treatment site and absence of Type I endoleak at the 1 month follow-up visit.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2010

Longer than P75 for all trials

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

April 29, 2010

Completed
25 days until next milestone

First Posted

Study publicly available on registry

May 24, 2010

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
4.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 29, 2017

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

May 28, 2019

Completed
Last Updated

October 29, 2021

Status Verified

October 1, 2021

Enrollment Period

3.2 years

First QC Date

April 29, 2010

Results QC Date

February 7, 2019

Last Update Submit

October 27, 2021

Conditions

Keywords

Post-approval observation of patients being treated according to the indications for use for the Talent Converter Stent Graft

Outcome Measures

Primary Outcomes (1)

  • Number of Subjects With Successful Secondary Endovascular Treatment

    The outcome measure is successful secondary endovascular treatment with the Talent Converter stent graft where treatment success is defined as successful vessel access, successful insertion of the delivery system, successful deployment of the Converter stent graft at the intended treatment site and absence of Type I endoleak at the 1 month follow-up visit.

    30 days

Study Arms (1)

Participants with Successful Secondary Endovascular Treatment

Device: Talent Converter Stent Graft and Talent Occluder with Occluder Delivery System

Interventions

All subject enrolled will be attempted to be treated with or will be treated with the Talent Converter Stent Graft

Participants with Successful Secondary Endovascular Treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All subjects who are treated with the Talent Converter Stent Graft according to the indications for use

You may qualify if:

  • Subjects in whom a vessel access procedure was/will be performed with the attempted introduction of the Talent Converter Stent Graft for use according to the indications for use in the Instructions for Use (IFU) 0-365 days prior to enrollment.
  • Subjects who are able to understand the nature of the study and give voluntary informed consent.
  • Subjects who are available for follow-up visits.
  • Subjects 18 years of age or older.

You may not qualify if:

  • Subjects in whom an attempted treatment was/will be performed with the Talent Converter Stent Graft other than (i.e., primary AUI) as a secondary endovascular intervention for patients having received prior endovascular repair with either a Talent or AneuRx bifurcated stent graft.
  • Subjects in whom an attempted treatment was/will be performed with the Talent Converter Stent Graft as a secondary endovascular intervention for patients having received prior endovascular repair with a bifurcated stent graft other than (i.e., Cook Zenith or Gore Excluder) a Talent or AneuRx bifurcated stent graft.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Aortic Aneurysm, Abdominal

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Limitations and Caveats

FDA allowed for early termination of the Talent Converter PAS because the device is no longer being manufactured, and exsisting inventory of the device has since expired, thus no statistical conclusions will be derived due to low enrollment.

Results Point of Contact

Title
Rianna Rapson
Organization
Medtronic

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 29, 2010

First Posted

May 24, 2010

Study Start

April 1, 2010

Primary Completion

June 1, 2013

Study Completion

September 29, 2017

Last Updated

October 29, 2021

Results First Posted

May 28, 2019

Record last verified: 2021-10